Literature DB >> 19846930

Effects of 5-FU on DNA synthesis and cytotoxicity of human lymphocytes induced by IL-2, TGF-beta3 and PGE2.

Avi Eisenthal1, Karin Eytan, Eli Brazowski, Gilad Gitstein, Ron Greenberg, Yehuda Skornick.   

Abstract

BACKGROUND: Low 5-fluorouracil (5-FU) concentrations cause a significant increase in DNA synthesis in mitogen-activated human lymphocytes.
MATERIALS AND METHODS: We explored 2.5 microM 5-FU-induced DNA synthesis by testing 5-FU activity in hypoxanthine-aminopterin-thymidine (HAT)-containing medium, and its effect on thymidylate synthase (TS) activity and CD25 expression in interleukin (IL)-2-activated human peripheral blood mononuclear cells (PBMCs) and the combined effects with prostaglandin E(2) (PGE(2)) and transforming growth factor (TGF)-beta3.
RESULTS: The co-stimulatory effect of 2.5 microM 5-FU on DNA synthesis was abrogated in HAT-cultured medium. 5-FU substantially reduced TS activity by 50% in IL-2-activated PBMCs. 5-FU combined with TGF-beta3 and PGE(2) did not alter their inhibitory effects on IL-2-activated natural killer cell cytotoxicity, but substantially affected increased DNA synthesis of cells cultured in IL-2 and co-cultured with 10 ng/ml TGF-beta3 and 10 microM PGE(2).
CONCLUSION: Low 5-FU concentrations increase DNA synthesis in lymphocytes and exert a co-stimulatory activity on TGF-beta3 and PGE(2) modulation of IL-2-activated lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19846930

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  A suspected case of drug-induced tubulointerstitial nephritis by pilocarpine hydrochloride.

Authors:  Teruhiro Fujii; Kentaro Kawasoe; Yuki Nishizawa; Jumpei Kashima; Akiko Tonooka; Akihito Ohta; Kosaku Nitta
Journal:  CEN Case Rep       Date:  2019-05-10

2.  Evaluation of the drug-induced lymphocyte stimulation test for diagnosing mesalazine allergy.

Authors:  Daisuke Saito; Mari Hayashida; Taro Sato; Shintaro Minowa; Osamu Ikezaki; Tatsuya Mitsui; Miki Miura; Akihito Sakuraba; Tadakazu Hisamatsu
Journal:  Intest Res       Date:  2018-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.